United Therapeutics Corporation - logo

United Therapeutics Corporation - Company & Market Research Reports

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market - Product Thumbnail Image

Global Respiratory Complications Therapeutics Market to 2022 - Innovative Pneumonia and Pulmonary Arterial Hypertension Therapies Dominate Varied Disease Market

  • Report
  • 197 Pages
From
Diabetes & Obesity Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Diabetes & Obesity Drug Development Pipeline Review, 2016

  • Report
  • 560 Pages
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (2nd Edition), 2018-2030

  • Report
  • 350 Pages
From
PDE Inhibitors Market, 2016-2026 - Product Thumbnail Image

PDE Inhibitors Market, 2016-2026

  • Report
  • 223 Pages
From
T-Cell Immunotherapy Market (2nd Edition), 2017-2030 - Product Thumbnail Image

T-Cell Immunotherapy Market (2nd Edition), 2017-2030

  • Report
  • 654 Pages
From
Pulmonary Arterial Hypertension (PAH): Drug Development Pipeline Study, H1 2018 - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH): Drug Development Pipeline Study, H1 2018

  • Report
  • 118 Pages
From
Blood Pressure Disorders Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Blood Pressure Disorders Drug Development Pipeline Review, 2018

  • Report
  • 213 Pages
From
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • 251 Pages
From
Antibody Drug Conjugates Market (4th Edition) 2017-2030 - Product Thumbnail Image

Antibody Drug Conjugates Market (4th Edition) 2017-2030

  • Report
  • 556 Pages
From
Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Strategic Business Report

  • Report
  • 161 Pages
From
Cardiovascular Drugs: Global Markets to 2022 - Product Thumbnail Image

Cardiovascular Drugs: Global Markets to 2022

  • Report
  • 174 Pages
From
Global Pulmonary Arterial Hypertension (PAH) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026 - Product Thumbnail Image

Global Pulmonary Arterial Hypertension (PAH) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • Report
From
Pulmonary Hypertension Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Pulmonary Hypertension Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 521 Pages
From
Pulmonary Arterial Hypertension Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Pulmonary Arterial Hypertension Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 348 Pages
From
Portal Hypertension Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Portal Hypertension Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 106 Pages
From
Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Idiopathic Pulmonary Hypertension Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 67 Pages
From
Critical Limb Ischemia Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Critical Limb Ischemia Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 149 Pages
From
Bronchopulmonary Dysplasia Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Bronchopulmonary Dysplasia Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 70 Pages
From
Pulmonary Arterial Hypertension (PAH) Market By Drug Class (Prostacyclin And Prostacyclin Analogs, Soluble Guanylate Cyclase (SGC) Stimulators, Endothelin Receptor Antagonists (ERA), Phosphodiesterase 5 (PDE-5)) And Segment Forecasts To 2025 - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH) Market By Drug Class (Prostacyclin And Prostacyclin Analogs, Soluble Guanylate Cyclase (SGC) Stimulators, Endothelin Receptor Antagonists (ERA), Phosphodiesterase 5 (PDE-5)) And Segment Forecasts To 2025

  • Report
  • 90 Pages
From
Global Cerebrovascular Diseases Treatment Research and Forecast 2018-2023 - Product Thumbnail Image

Global Cerebrovascular Diseases Treatment Research and Forecast 2018-2023

  • Report
From
Loading Indicator
adroll